901 filings
Page 3 of 46
8-K
g5kohurw6p0v0
19 Jul 23
Departure of Directors or Certain Officers
4:30pm
3
6zxrznrtor xifeok3nr
19 Jul 23
Armata Pharmaceuticals / Deborah Birx ownership change
9:56am
SC 13D/A
4bbbutl4gfwow104xp8
11 Jul 23
Armata Pharmaceuticals / Innoviva ownership change
8:27am
8-K
g2j0t67ms 6e
11 Jul 23
Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics
8:15am
8-K
87e7r6u52pnatiqt7r9
27 Jun 23
Results of Operations and Financial Condition
4:30pm
8-K
ganksiq
11 May 23
Armata Pharmaceuticals Announces First Quarter 2023 Results and Provides Corporate Update
9:04pm
3
795 bfy4sssdbkyww
8 May 23
Armata Pharmaceuticals / Julianne Averill ownership change
2:14pm
8-K
8dlrmm 39p
5 May 23
Departure of Directors or Certain Officers
4:38pm
EFFECT
enorsn hpg5bb87
7 Apr 23
Notice of effectiveness
12:15am
424B3
cleoupztk
6 Apr 23
Prospectus supplement
4:08pm
CORRESP
orgvud vcx1pn
5 Apr 23
Correspondence with SEC
12:00am
8-K
45jtzw07nlt9z j7yyg
16 Mar 23
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2022 Results and Provides Corporate Update
4:10pm
8-K
xxpwji828njg
6 Mar 23
Armata Pharmaceuticals Announces Positive Topline Data from Phase 1b/2a SWARM-P.a. Clinical Trial of Inhaled AP-PA02 in Patients with Cystic Fibrosis
6:10am
UPLOAD
06n3m
17 Feb 23
Letter from SEC
12:00am
3
7s5u4colkoz6aa
7 Feb 23
Armata Pharmaceuticals / Erin Butler ownership change
4:00pm
4
yfxzennyjonkx ql
12 Jan 23
Change in insider ownership
9:21pm